← Eichor
Study identifier: NCT03809585 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Observational Study of Iris Tumors

Condition: Iris Tumor  ·  Sponsor: Oregon Health and Science University

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Denzil Romfh, OD  ·  503-494-4351  ·  romfhd@ohsu.edu

Humberto Martinez, COT  ·  503-494-7712  ·  martinhu@ohsu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Oregon Health & Science UniversityPortland, Oregon, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03809585